HH Kim
CEO, MetaVia
False
Advertisement
A Turning Point in MASH
January 8, 2026
A billion-dollar acquisition, breakthrough clinical data, and a shifting scientific paradigm are pushing MASH out of the shadows and into a new era of metabolic medicine.
3 min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
